EUDA Health Holdings Ltd Selling and Marketing Expense
EUDA Health Holdings Ltd (EUDA) reported Selling and Marketing Expense of $1.28 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-04-28
- EUDA Health Holdings Ltd selling and marketing expense for the quarter ending 2023-06-30 was -$27.30K.
- EUDA Health Holdings Ltd selling and marketing expense for the quarter ending 2023-03-31 was $404.77K, a 9.96% increase year-over-year.
- EUDA Health Holdings Ltd selling and marketing expense for the quarter ending 2022-03-31 was $368.09K.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 6 month | Selling and Marketing Expense 12 month | Selling and Marketing Expense 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | $1.28M 20-F · filed 2026-04-28 | |||
| 2025-06-30 | $58.95K 6-K · filed 2025-10-01 | |||
| 2024-12-31 | $129.87K 20-F · filed 2026-04-28 | |||
| 2024-06-30 | $34.94K 6-K · filed 2025-10-01 | |||
| 2023-12-31 | $533.56K 20-F · filed 2026-04-28 | |||
| 2023-06-30 | -$27.30K derived: 6-K 6 month − 10-Q 3 month · filed 2024-10-18 | $377.47K 6-K · filed 2024-10-18 | ||
| 2023-03-31 | $404.77K 10-Q · filed 2023-07-31 | |||
| 2022-12-31 | $935.57K 20-F/A · filed 2025-09-24 | $1.90M 10-K · filed 2023-06-28 | ||
| 2022-03-31 | $368.09K 10-Q · filed 2023-07-31 | |||
| 2021-12-31 | $333.66K 20-F · filed 2024-05-09 | $1.26M 10-K · filed 2023-06-28 |